125 related articles for article (PubMed ID: 17225281)
21. In brief: immune based therapies.
Proj Inf Perspect; 1999 Sep; (28):24. PubMed ID: 11367364
[TBL] [Abstract][Full Text] [Related]
22. Is autovaccination dead?
Hirschel B
Res Initiat Treat Action; 2003; 9(2):16. PubMed ID: 14989201
[No Abstract] [Full Text] [Related]
23. Virology. Moving forward in HIV vaccine development.
Letvin NL
Science; 2009 Nov; 326(5957):1196-8. PubMed ID: 19965456
[No Abstract] [Full Text] [Related]
24. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.
Longo O; Tripiciano A; Fiorelli V; Bellino S; Scoglio A; Collacchi B; Alvarez MJ; Francavilla V; Arancio A; Paniccia G; Lazzarin A; Tambussi G; Din CT; Visintini R; Narciso P; Antinori A; D'Offizi G; Giulianelli M; Carta M; Di Carlo A; Palamara G; Giuliani M; Laguardia ME; Monini P; Magnani M; Ensoli F; Ensoli B
Vaccine; 2009 May; 27(25-26):3306-12. PubMed ID: 19208456
[TBL] [Abstract][Full Text] [Related]
25. A new approach: immune-based treatments against HIV.
Berger DS
Posit Aware; 2007; 18(3):43-4. PubMed ID: 17526118
[No Abstract] [Full Text] [Related]
26. Report from the 12th Retrovirus Conference. Immune-based therapies for established HIV infection.
Henry K
AIDS Clin Care; 2005 Apr; 17(4):35-6. PubMed ID: 15877316
[No Abstract] [Full Text] [Related]
27. A pilot study on the use of self-mononuclear cell vaccines for tertiary prevention in early HIV disease.
Allen AD; Mathisen GE; Glover N
AIDS; 1993 May; 7(5):743-4. PubMed ID: 8318184
[No Abstract] [Full Text] [Related]
28. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
29. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
30. Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan Dawson.
Moss R
STEP Perspect; 1998; 98(2):13-6. PubMed ID: 11365540
[TBL] [Abstract][Full Text] [Related]
31. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic vaccination: where are we now?
Rosenberg ES
AIDS Clin Care; 2003 Jan; 15(1):1-3. PubMed ID: 12685420
[No Abstract] [Full Text] [Related]
33. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
34. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
35. Salk therapy begins.
Posit Aware; 1996; 7(3):7. PubMed ID: 11363429
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy).
Angel JB; Routy JP; Graziani GM; Tremblay CL
J Acquir Immune Defic Syndr; 2015 Oct; 70(2):122-8. PubMed ID: 26375464
[TBL] [Abstract][Full Text] [Related]
37. HIV immunotherapeutic vaccines.
Peters BS
Antivir Chem Chemother; 2000 Sep; 11(5):311-20. PubMed ID: 11142629
[TBL] [Abstract][Full Text] [Related]
38. [Vaccinations of HIV-infected travelers].
Couzigou C; Voyer C; Shaghaghi CK; Bourée P; Vittecoq D
Med Mal Infect; 2009 Jan; 39(1):21-8. PubMed ID: 18723304
[TBL] [Abstract][Full Text] [Related]
39. Can immune systems be trained to fight HIV?
Balter M
Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544
[No Abstract] [Full Text] [Related]
40. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
Ensoli B; Fiorelli V; Ensoli F; Lazzarin A; Visintini R; Narciso P; Di Carlo A; Monini P; Magnani M; Garaci E
AIDS; 2008 Oct; 22(16):2207-9. PubMed ID: 18832884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
